Minimed Group, Inc. MMED
IPO
NASDAQ
| 07/31/2026 | 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/25/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 2.87B | 2.79B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 2.87B | 2.79B |
| Cost of Revenue | -- | -- | -- | 1.25B | 1.22B |
| Gross Profit | -- | -- | -- | 1.62B | 1.57B |
| SG&A Expenses | -- | -- | -- | 1.11B | 1.10B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -16.50M | -22.50M |
| Total Operating Expenses | -- | -- | -- | 2.81B | 2.74B |
| Operating Income | -- | -- | -- | 62.00M | 41.50M |
| Income Before Tax | -- | -- | -- | -137.00M | -148.00M |
| Income Tax Expenses | -- | -- | -- | 63.50M | 53.50M |
| Earnings from Continuing Operations | -- | -- | -- | -200.50 | -201.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -15.00M | -15.00M |
| Net Income | -- | -- | -- | -215.50M | -216.50M |
| EBIT | -- | -- | -- | 62.00M | 41.50M |
| EBITDA | -- | -- | -- | 215.00M | 189.50M |
| EPS Basic | -- | -- | -- | -1.48 | -0.80 |
| Normalized Basic EPS | -- | -- | -- | 0.09 | 0.09 |
| EPS Diluted | -- | -- | -- | -1.48 | -0.80 |
| Normalized Diluted EPS | -- | -- | -- | 0.09 | 0.09 |
| Average Basic Shares Outstanding | -- | -- | -- | 758.37M | 758.37M |
| Average Diluted Shares Outstanding | -- | -- | -- | 1.01B | 758.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |